In Silico Tau Protein Kinase I Inhibitory Activity of Some Commercially Available Flavonoids
Abstract
Molecular docking is a frequently used tool in computer-aided structure-based rational drug design. Flavonoids are a group of natural products which exhibits various biological and pharmacological activities. The primary objective of this study was to investigate the tau protein kinase I inhibitory activity of flavonoids using in silico docking studies. Memantine, a known neuro-receptor antagonist is currently used in the treatment of Alzheimer’s disease (AD). In silico docking studies were carried out using AutoDock 4.2, based on the Lamarckian genetic algorithm principle. The results showed that all the selected flavonoids showed binding energy ranging between −6.98 to −5.95 kcal/mol when compared with that of the standard (−5.89 kcal/mol). Inhibition constant (7.65 to 43.64 µM) and intermolecular energy (−8.47 to −7.15 kcal/mol) of the flavonoids also coincide with the binding energy. All the selected flavonoids contributed tau protein kinase I inhibitory activity because of its structural properties. These molecular docking analyses could lead to the further development of potent tau protein kinase I inhibitors for the treatment of AD. Further investigations on the above compounds and in vivo studies are necessary to develop potential chemical entities for the prevention and treatment of AD.
Keywords: Alzheimer’s Disease, Flavonoids, Binding Energy, Inhibition Constant, Intermolecular Energy
Cite this Article:
Madeswaran A, Asokkumar K. In silico tau protein kinase I inhibitory activity of some commercially available flavonoids. Research & Reviews: A Journal of Drug Design & Discovery. 2015. 2(1): 6–12p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
